Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens.
about
Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-Fas-induced apoptosisThe impact of sphingosine kinase-1 in head and neck cancer.Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.The development of aggressive cancer: a possible role for sphingolipids.Ceramide: second messenger or modulator of membrane structure and dynamics?Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease.Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cellsSphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport.C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors.Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels.Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.An obligate role for membrane-associated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils.The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytesCaspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death.De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells.Attenuation of acetic acid-induced gastric ulcer formation in rats by glucosylceramide synthase inhibitors.Glucosylceramide synthases, a gene family responsible for the biosynthesis of glucosphingolipids in animals, plants, and fungi.Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance
P2860
Q28343579-13B5CB70-859B-4F8B-B8C3-D36458C0CF34Q33649748-65E06324-F65E-4B82-95EA-A750F366A637Q33733991-F9E7F111-5E77-45BD-858B-0F0FEBD827D4Q34295244-DD457CDD-DE0C-43B1-9AC3-E68E21633D28Q34334511-C815359E-85ED-413D-9B69-483581CE0A7AQ34718233-EBD7E4E7-4BD2-4368-B573-4202A43652ECQ34789995-7DDB5F35-51FF-4C77-B0F7-609F17F237CEQ34798714-8668F4C8-E211-4A99-8ACE-21EDDB1F0E26Q34984863-C9E0117A-8635-4DF3-97BC-FCADDBE70849Q35536435-7A55438C-66D7-433E-BCF7-3A4AC5E227BAQ36055464-192F9A99-05E3-42D1-A962-48B658E4FAA8Q36600615-E0628F60-DB3E-429E-8F2A-56903D76D162Q39421907-23FE4CD7-6F37-4995-87E5-A5915A07B94AQ39571008-CC950C0F-2FF9-4A95-B5F6-3A1A68F825F1Q40176292-817F495B-CBE0-4DCE-936D-BFB903FB5BB3Q40572637-6D157EAA-EADD-48DF-BD92-7BD68EA0B9D5Q41811577-A5844678-5988-49A6-8142-D0A584F31B9FQ41837151-BEBA230F-A512-4312-80B9-1B5A319E2488Q42321804-949A0552-71A5-40B0-A214-FA7881DC3C8AQ43271690-41589F35-4499-4ED2-8E2C-2939B8346913Q44799706-F80B7DB4-F638-4ABE-8D03-17AB1636F4FCQ46871022-D0ADDB7C-5A08-422D-9BD4-42E657DE4148Q48354725-7E8346D5-5DC4-4474-8105-60E017D2160EQ57374107-ADF177A4-1CF5-4853-8490-01DE41415123
P2860
Glucosylceramide synthase does not attenuate the ceramide pool accumulating during apoptosis induced by CD95 or anti-cancer regimens.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@ast
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@en
type
label
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@ast
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@en
prefLabel
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@ast
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@en
P2093
P2860
P356
P1476
Glucosylceramide synthase does ...... CD95 or anti-cancer regimens.
@en
P2093
van Blitterswijk WJ
P2860
P304
34810-34817
P356
10.1074/JBC.M005142200
P407
P577
2000-11-01T00:00:00Z